These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4153738)

  • 1. [Essential hypertension: Renin and aldosterone, key to pathogeny and therapy?].
    Bühler FR
    Schweiz Med Wochenschr; 1974 Jul; 104(29):1013-22. PubMed ID: 4153738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic and hormonologic basis of the treatment of arterial hypertension].
    Guédon J; Lucsko M; Chaignon M
    Arch Mal Coeur Vaiss; 1974 Oct; 67(10):1145-55. PubMed ID: 4156640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of cardiac output, plasma volume, plasma renin activity and aldosterone secretion in patients with essential hypertension treated with beta-blocking agents and diuretics].
    Salerno L; Licata G; Sparacino V; Custro N; Indovina I
    Clin Ter; 1979 Aug; 90(3):223-32. PubMed ID: 45260
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination of betablocking-vasodilator and diuretic agents in the treatment of arterial hypertension. Changes in Hemodynamics and plasma-renin levels].
    Fernández-Andrade C; Herrera Carranza M; Villalobos Galán E; Mateos Aguilar J; Quereda C; Navarro R; Martinez Martin A; Mendoza Llera M
    Rev Clin Esp; 1978 Mar; 148(5):491-6. PubMed ID: 27844
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ambulant and stationary determination of the renin-sodium index in the classification and treatment of essential hypertension].
    Bühler FR; Patel U; Marbet G
    Schweiz Med Wochenschr; 1974 Dec; 104(49):1802-5. PubMed ID: 4156423
    [No Abstract]   [Full Text] [Related]  

  • 6. The classification and treatment of essential hypertension using the renin-sodium index for vasoconstriction-volume analysis.
    Laragh JH
    Johns Hopkins Med J; 1975 Oct; 137(4):184-94. PubMed ID: 1185911
    [No Abstract]   [Full Text] [Related]  

  • 7. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
    Pedersen EB
    Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641
    [No Abstract]   [Full Text] [Related]  

  • 8. A physiological basis for the treatment of essential hypertension.
    Weber MA; Laragh JH
    Bull N Y Acad Med; 1978 Nov; 54(10):931-43. PubMed ID: 280391
    [No Abstract]   [Full Text] [Related]  

  • 9. [Measurement of plasma renin activity, blood volume and exchangeable sodium: an aid in the orientation of treatment of essential arterial hypertension].
    Olmer M; Ducros J; Grandvuillemin M; Salvadori JM
    Sem Hop; 1977 May; 53(20):1147-53. PubMed ID: 20666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances in hypertension therapy (author's transl)].
    Würsten D; Siegenthaler G; Siegenthaler W; Nussberger J; Schmied U; Beckerhoff R; Vetter W
    Schweiz Rundsch Med Prax; 1975 Apr; 64(13):373-82. PubMed ID: 2907
    [No Abstract]   [Full Text] [Related]  

  • 11. [Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
    Bühler FR
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1798-806. PubMed ID: 13490
    [No Abstract]   [Full Text] [Related]  

  • 12. [The potential of beta-blockaders in the management of hypertension].
    Bühler FR; Kowski W; Bolli P; Bertel O
    Internist (Berl); 1978 Sep; 19(9):510-9. PubMed ID: 29849
    [No Abstract]   [Full Text] [Related]  

  • 13. [beta-blockers in hypertension with renal failure].
    Guédon J; Aubert P; Lucsko M; Chaignon M
    Nouv Presse Med; 1978 Sep; 7(31):2795-7. PubMed ID: 30967
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathophysiology of propranolol in hypertension.
    Frohlich ED
    South Med J; 1977 Jan; 70(1):95-9. PubMed ID: 14402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The state of certain humoral systems and haemodynamics in healthy subjects and in patients with essential hypertension with excessive salt intake.
    Nekrasova AA; Fatula MI; Patrusheva NF; Chernova NA; Suvorov YI; Gazarian GA
    Cor Vasa; 1980; 22(1-2):85-96. PubMed ID: 6995019
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physiopathological approach to the therapy of arterial hypertension in diabetic nephropathy].
    Cannella G; Scolari F; Brignani A; Maiorca R
    Minerva Nefrol; 1982; 29(3 Suppl):37-44. PubMed ID: 6128701
    [No Abstract]   [Full Text] [Related]  

  • 17. Low renin essential hypertension.
    Sennette JA
    J Tenn Med Assoc; 1974 Mar; 67(3):211-2. PubMed ID: 4595013
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-adrenergic regulation of circadian rhythmicity of the renin-angiotensin-aldosterone system in five subtypes of essential hypertension.
    Cugini P; Manconi R; Mancini A; Serdoz R; Meucci T; Scavo D
    G Ital Cardiol; 1980; 10(2):184-90. PubMed ID: 6102942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of the human circulation. Regulation by autonomic nervous system and renin-angiotensin system, and influence of blood volume on cardiac output and blood pressure.
    Luetscher JA; Boyers DG; Cuthbertson JG; McMahon DF
    Circ Res; 1973 May; 32():Suppl 1:84-98. PubMed ID: 4351360
    [No Abstract]   [Full Text] [Related]  

  • 20. [Essential arterial hypertension with low renin].
    Conte G; Semplicini A
    Recenti Prog Med; 1980 Mar; 68(3):280-5. PubMed ID: 6117117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.